Axol Bioscience Ltd., based in Cambridgeshire, U.K., has licensed technology developed at the Indiana University School of Medicine.
The license agreement with Indiana University Research and Technology Corp. is for technology that creates cells found on the interior of blood vessels. It was developed by Dr. Mervin C. Yoder and Nutan Prasain, Ph.D.
“We developed the methods that were required to direct the differentiation of the stem cells into endothelial colony forming cells, or ECFC, the progenitor cells that give rise to endothelial cells,” Yoder said. “The ECFC-derived endothelial cells display potent proliferative potential and in vivo vessel formation.”
Axol Bioscience will produce the cells and sell them to industrial and academic researchers.
More information about the licensing agreement and the technology are available here.